Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.97% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VIVS
3501
VivoSim Labs
VIVS
$1.15M
| $14.5K | ﹤0.01% |
2,636
-1,033
| -28% | -$5.23K |
|
3502
TDH Holdings
PETZ
$15.5M
| $13.8K | ﹤0.01% |
11,000
-4,200
| -28% | -$5.21K |
|
|
ZVSA
3503
DELISTED
ZyVersa Therapeutics
ZVSA
| $13.7K | ﹤0.01% |
+12,961
| New | +$20.5K |
|
|
CAPT
3504
DELISTED
Captivision
CAPT
| $13.7K | ﹤0.01% |
+19,366
| New | +$23.6K |
|
3505
Lucas GC Ltd
LGCL
$68.5M
| $13.5K | ﹤0.01% |
+560
| New | +$21K |
|
|
OMGA
3506
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $13.3K | ﹤0.01% |
17,820
-456,780
| -96% | -$455K |
|
|
CTOR
3507
Citius Oncology
CTOR
$76.9M
| $12.9K | ﹤0.01% |
+11,196
| New | +$12.6K |
|
|
ENFY
3508
DELISTED
Enlightify Inc
ENFY
| $12.9K | ﹤0.01% |
12,451
| – | – |
|
|
AMTD
3509
AMTD IDEA Group
AMTD
$72.1M
| $12.7K | ﹤0.01% |
10,566
-15,100
| -59% | -$19.2K |
|
|
XTKG
3510
DELISTED
X3 Holdings Co., Ltd. Class A Ordinary Shares
XTKG
| $12.4K | ﹤0.01% |
+74
| New | +$30.2K |
|
3511
IceCure Medical
ICCM
$10.3M
| $12K | ﹤0.01% |
+363
| New | +$8.31K |
|
3512
Acurx Pharmaceuticals
ACXP
$6.36M
| $11.9K | ﹤0.01% |
+734
| New | +$22.1K |
|
|
TSBX
3513
DELISTED
Turnstone Biologics
TSBX
| $11.9K | ﹤0.01% |
+23,900
| New | +$11.8K |
|
3514
TruGolf
TRUG
$971K
| $11.9K | ﹤0.01% |
+35
| New | +$10.9K |
|
|
SOPA
3515
DELISTED
Society Pass
SOPA
| $11K | ﹤0.01% |
12,277
+1,400
| +13% | +$1.31K |
|
3516
CaliberCos
CWD
$5.91M
| $10.9K | ﹤0.01% |
782
-122
| -13% | -$1.4K |
|
|
ECDA
3517
DELISTED
ECD Automotive Design
ECDA
| $10.4K | ﹤0.01% |
54
| – | – |
|
3518
Talphera
TLPH
$62.8M
| $10.3K | ﹤0.01% |
+19,643
| New | +$15.3K |
|
|
CBIO
3519
Crescent Biopharma
CBIO
$618M
| $10.2K | ﹤0.01% |
412
-7,399
| -95% | -$202K |
|
3520
TherapeuticsMD
TXMD
$24.1M
| $9.37K | ﹤0.01% |
+10,891
| New | +$15.3K |
|
3521
Matinas BioPharma
MTNB
$1.49M
| $9.27K | ﹤0.01% |
+18,170
| New | +$27.6K |
|
3522
GlucoTrack
GCTK
$2.82M
| $8.96K | ﹤0.01% |
+20
| New | +$25.4K |
|
|
GP
3523
GreenPower Motor Co
GP
$11.3M
| $8.38K | ﹤0.01% |
1,090
-950
| -47% | -$9.46K |
|
|
KUST
3524
Kustom Entertainment Inc
KUST
$859K
| $8.3K | ﹤0.01% |
+1
| New | +$25.1K |
|
3525
ZK International Group
ZKIN
$60.8M
| $8.28K | ﹤0.01% |
1,971
-72
| -4% | -$299 |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.